ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.verified

ARYX

Price:

$0.0005

Market Cap:

$237.58K

ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. The company uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of original drugs. Its products in clinical development portfolio include Tecarfarin (ATI-5923), an oral anticoagulant, which is in Phase III clinical development for the treatment of patients who are at risk for the formation of dangerous blood clots; and Budiodarone (ATI-2042), an oral antiarrhythmic agent that is in Phase IIb clinical development for the treatment of atrial fibrillation, a form of irregular heartbeat. The company's other clinical development products ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2007-11-07

Stock Exchange

PNK

Ticker

ARYX

The Enterprise Value as of November 2024 (TTM) for ARYx Therapeutics, Inc. (ARYX) is 4.52M

According to ARYx Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.52M. This represents a change of -89.02% compared to the average of 41.21M of the last 4 quarters.

ARYx Therapeutics, Inc. (ARYX) Historical Enterprise Value (quarterly & annually)

How has ARYX Enterprise Value performed in the past?

The mean historical Enterprise Value of ARYx Therapeutics, Inc. over the last ten years is 16.54M. The current 4.52M Enterprise Value has changed 2.63% with respect to the historical average. Over the past ten years (40 quarters), ARYX's Enterprise Value was at its highest in in the June 2008 quarter at 120.18M. The Enterprise Value was at its lowest in in the December 2006 quarter at -538200.00.

Quarterly (TTM)
Annual

Average

16.54M

Median

6.08M

Minimum

-22564500.00

Maximum

92.36M

ARYx Therapeutics, Inc. (ARYX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ARYx Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Enterprise Value = 92.36M

Minimum Annual Increase = -249.25%

Minimum Annual Enterprise Value = -22564500.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
200992.36M174.25%
200833.68M-249.25%
2007-22564500.004.09%
2006-538200.00-108.85%
20056.08MInfinity%
20040-100.00%

ARYx Therapeutics, Inc. (ARYX) Average Enterprise Value

How has ARYX Enterprise Value performed in the past?

The current Enterprise Value of ARYx Therapeutics, Inc. (ARYX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

34.49M

5-year avg

21.80M

10-year avg

16.54M

ARYx Therapeutics, Inc. (ARYX) Enterprise Value vs. Peers

How is ARYX’s Enterprise Value compared to its peers?

ARYx Therapeutics, Inc.’s Enterprise Value is less than Medicure Inc. (0), greater than Mountain High Acquisitions Corp. (3.69M), greater than Creative Edge Nutrition, Inc. (85.33K), greater than OWC Pharmaceutical Research Corp. (45.28K), greater than Ascend Wellness Holdings, Inc. (49.75K), less than Incannex Healthcare Limited (676.82M), less than Silver Spike Investment Corp. (37.03M), less than Phibro Animal Health Corporation (33.56M), less than Supernus Pharmaceuticals, Inc. (1.38B), less than null (1.91B),

Build a custom stock screener for ARYx Therapeutics, Inc. (ARYX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ARYx Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ARYx Therapeutics, Inc. (ARYX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ARYx Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ARYx Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for ARYx Therapeutics, Inc. (ARYX)?

What is the 3-year average Enterprise Value for ARYx Therapeutics, Inc. (ARYX)?

What is the 5-year average Enterprise Value for ARYx Therapeutics, Inc. (ARYX)?

How does the current Enterprise Value for ARYx Therapeutics, Inc. (ARYX) compare to its historical average?